Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loqmane Seridi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Lupus|February 25, 2021
Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibitionLoqmane Seridi, Matteo Cesaroni, Ashley Orillion, et al.
ACR Open Rheumatology|August 9, 2023
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled TrialsStefan Siebert, Kristen M Sweet, Christopher T Ritchlin, et al.
The Lancet. Rheumatology|January 26, 2024
First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trialJarrat Jordan, Jacqueline Benson, Walter Winn Chatham, et al.
Annals of the Rheumatic Diseases|July 7, 2022
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosusRonald F van Vollenhoven, Kenneth C Kalunian, Thomas Dörner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2024
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic ArthritisStefan Siebert, Laura C Coates, Georg Schett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2020
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus ErythematosusMatteo Cesaroni, Loqmane Seridi, Matthew J Loza, et al.
BMC Genomics|March 2, 2016
Hologenome analysis of two marine sponges with different microbiomesTaewoo Ryu, Loqmane Seridi, Lucas Moitinho-Silva, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Lupus|February 25, 2021
Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibitionLoqmane Seridi, Matteo Cesaroni, Ashley Orillion, et al.
ACR Open Rheumatology|August 9, 2023
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled TrialsStefan Siebert, Kristen M Sweet, Christopher T Ritchlin, et al.
The Lancet. Rheumatology|January 26, 2024
First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trialJarrat Jordan, Jacqueline Benson, Walter Winn Chatham, et al.
Annals of the Rheumatic Diseases|July 7, 2022
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosusRonald F van Vollenhoven, Kenneth C Kalunian, Thomas Dörner, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2024
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic ArthritisStefan Siebert, Laura C Coates, Georg Schett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2020
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus ErythematosusMatteo Cesaroni, Loqmane Seridi, Matthew J Loza, et al.
BMC Genomics|March 2, 2016
Hologenome analysis of two marine sponges with different microbiomesTaewoo Ryu, Loqmane Seridi, Lucas Moitinho-Silva, et al.
Pageof 2